Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FL115 injection plus sintilimab in advanced solid tumors
CTR20255098Phase 2Active
- Sponsor
- Suzhou Furong Biotechnology
- Start
- Jan 2026
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes, Cytokines & Interferons → Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of FL-115 in Nonhematologic neoplasms, sponsored by Suzhou Furong Biotechnology. Started Jan 2026; status: active.
02
Drugs
FL-115
03
Conditions
Nonhematologic neoplasms
Beyond the preview
Go deeper on CTR20255098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20255098.